Abbott Laboratories ABT

NYS: ABT | ISIN: US0028241000 15/07/2026

89,27 USD (+0,35%)

(+0,35%) 15/07/2026

Grafiek Abbott Laboratories

Grafiek Abbott Laboratories

1 dag1d 0,35%
1 week1w -5,43%
1 maand1m -1,49%
3 maanden3m -6,49%
6 maanden6m -26,68%
1 jaar1j -32,24%
5 jaar5j -24,03%

donderdag 16 juli 2026, 13:00

Kwartaalcijfers (2de kwartaal)

Abbott Laboratories in het nieuws

Toon enkel gratis nieuws

16 juli 2026 · Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance · Persbericht

25 juni 2026 · Abbott hosts conference call for second-quarter earnings · Persbericht

24 juni 2026 · ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing · Persbericht

22 juni 2026 · New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next generation of parents · Persbericht

12 juni 2026 · Abbott declares 410th consecutive quarterly dividend · Persbericht

8 juni 2026 · New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers · Persbericht

6 juni 2026 · New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis · Persbericht

27 mei 2026 · Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes · Persbericht

27 mei 2026 · ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening · Persbericht

26 mei 2026 · Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026 · Persbericht

Profiel Abbott Laboratories

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Medische Specialiteiten

Website: www.abbott.com

Hoofdzetel: Abbott Park, Illinois Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe